Primary care treatment guidelines for skin infections in Europe: Congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community

BMC Family Practice

Volumn 15, Issue 1, 2014, Pages

  Van Bijnen, Evelien M E ^a   Paget, W John ^a   Den Heijer, Casper D J ^b   Stobberingh, Ellen E ^b   Bruggeman, Cathrien A ^b   Schellevis, François G ^a,c   Hoffmann, Kathryn ^d   Apfalter, Petra ^e   Goossens, Herman ^f   Ieven, Greet ^f   Bartholomeeusen, Stefaan ^g   Katic, Milica ^h   Budimir, Ana ⁱ   Hebbrecht, Gilles ^j   Kolozsvári, László ^k   Konya, Jozsef ^k   Mölstad, Sigvard ^l   Matussek, Andreas ^m   Bolibar, Bonaventura ⁿ   Grenzner, Elisabet ^o   Korevaar, Joke ^a   Pringle, Mike ^p   Fleming, Douglas ^q   Lovering, Andrew ^r   more..

^a NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e ELISABETHINEN HOSPITAL   (Austria)

^f UNIVERSITY OF ANTWERP   (Belgium)

^g UNIVERSITY OF LEUVEN   (Belgium)

^h UNIVERSITY OF ZAGREB   (Croatia)

ⁱ KBC Zagreb   (Croatia)

^j French Society of General Medicine   (France)

^k UNIVERSITY OF DEBRECEN   (Hungary)

^l LUND UNIVERSITY   (Sweden)

^m RYHOV COUNTY HOSPITAL   (Sweden)

ⁿ INSTITUT UNIVERSITARI D'INVESTIGACIÓ EN ATENCIÓ PRIMÀRIA JORDI GOL   (Spain)

^o INSTITUT CATALÀ DE LA SALUT   (Spain)

^p UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^q ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

^r NORTH BRISTOL NHS TRUST   (United Kingdom)

more..

Author keywords

Antibiotic resistance; Primary care; Skin infections; Treatment guidelines

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; PENICILLIN DERIVATIVE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; CHILD; COMMUNITY-ACQUIRED INFECTIONS; DRUG EFFECTS; EUROPE; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NOSE CAVITY; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIMARY HEALTH CARE; STANDARDS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; EUROPE; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NASAL CAVITY; PENICILLINS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 84936752239     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/s12875-014-0175-8     Document Type: Article

References (36)

1. European Commission: Staff working paper of the services of the Commission on antimicrobial resistance. http://ec.europa.eu/food/food/ biosafety/salmonella/antimicrobial-resistance.pdf Accessed 8 August 2014.
2. European Centre for Disease Prevention and Control (ECDC): Annual epidemiological report. http://www.ecdc.europa.eu/en/publications/ Publications/1111-SUR-Annual-Epidemiological-Report- on-Communicable-Diseases-in-Europe.pdf Accessed 8 August 2014.
3. European Academies Science Advisory Counsil (EASAC): Tackling antibacterial resistance. http://www.easac.eu/fileadmin/PDF-s/ reports-statements/Tackling.pdf Accessed 8 August 2014.
4. Den Heijer CDJ, Van Bijnen EME, Paget WJ, Pringle M, Goossens H, Bruggeman CA, Schellevis FG, Stobberingh EE, APRES Study Team: Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant Staphylococcus aureus: a European cross-sectional study. Lancet Infect Dis 2013, 13:409-415.
5. Goossens H, Ferech M, Vander Stichele SR, Elseviers M, ESAC Project Group: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005, 365:579-587.
6. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD: Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010, 340:c2096.
7. Muller A, Coenen S, Monnet DL, Goossens H, ESAC Project Group: European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe, 1998-2005. Euro Surveill 2007, 12(41):pi=3284.
8. Carrie AG, Zhanel GG: Antibacterial use in community practice: assessing quantity, indications and appropriateness, and relationship to the development of antibacterial resistance. Drugs 1999, 57:871-881.
9. Zetola N, Francis JS, Nuermberger EL, Bishai WR: Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005, 5:275-286.
10. Cosgrove SE, Carmeli Y: The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 2003, 36:1433-1437.
11. Infectious diseases society of America: Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis 2011, 52(suppl 5):S397-S428.
12. Kronenberg A, Koenig S, Droz S, Mühlemann K: Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting. Clin Microbiol Infect 2011, 17:1845-1851.
13. Van Bijnen EME, Paget J, Den Heijer CDJ, Stobberingh EE, Bruggeman CA, Schellevis FG, in collaboration with the APRES study team: Evidence-based primary care treatment guidelines for skin infections in Europe: a comparative analysis. Eur J Gen Pract 2014. In press.
14. Fleming DM, Elliot AJ: Skin infections and antibiotic prescribing: a comparison of surveillance and prescribing data. Br J Gen Pract 2007, 57:569-573.
15. May L, Porter C, Tribble D, Armstrong A, Mostafa M, Riddle M: Self-reported incidence of skin and soft tissue infections among deployed US military. Travel Med Infect Dis 2011, 9:213-220.
16. Miller LG, Kaplan SL: Staphylococcus aureus: a community pathogen. Infect Dis Clin North Am 2009, 23:35-52.
17. Ray GT, Suaya JA, Baxter R: Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study. BMC Infect Dis 2013, 13:252-262.
18. Carleton HA, An Diep B, Charlebois ED, Sensabaugh GF, Perdreau-Remington F: Community-adapted methicillin-resistant Staphylococcus aureus: population dynamics of an expanding community reservoir of MRSA. J Infect Dis 2004, 190:1730-1738.
19. Kluytmans-VandenBergh MFQ, Kluytmans JAJW: Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clin Microbiol Infect 2006, 12(Suppl 1):9-15.
20. Salgado CD, Farr BM, Calfee DP: Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003, 36:131-139.
21. Skov RL, Jensen KS: Community-associated meticillin-resistant Staphylococcus aureus as a cause of hospital-acquired infections. J Hosp Infect 2009, 73:364-370.
22. Sommer MOA, Church GM, Dantas G: The human microbiome harbors a diverse reservoir of antibiotic resistance genes. Virulence 2010, 4:299-303.
23. De Lastours V, Chau F, Tubach F, Pasquet B, Ruppé E, Fantin B: Independent behavior of commensal flora for carriage of fluoroquinolone-resistant bacteria in patients at admission. Antimicrob Agents Chemother 2010, 54:5193-5200.
24. Van Bijnen EME, Den Heijer CDJ, Paget WJ, Stobberingh EE, Verheij RA, Bruggeman CA, Pringle M, Goossens H, Schellevis FG: The appropriateness of prescribing antibiotics in the community in Europe: study design. BMC Infect Dis 2011, 11:293.
25. WertheimHF, Melles DC, Vos MC, Van LeeuwenW, Van Belkum A, Verbrugh HA, Nouwen JL: The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005, 5:751-762.
26. Miller LG, Eells SJ, Taylor AR, David MZ, Ortiz N, Zychowski D, Kumar N, Cruz D, Boyle-Vavra S, Daum RS: Staphylococcus aureus colonization among household contacts of patients with skin infections: risk factors, strain discordance, and complex ecology. Clin Infect Dis 2012, 54(11):1523-1535.
27. European Committee on Antimicrobial Susceptibility Testing: EUCAST Definitive Document E.DEF 3.1, June 2000: Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin Microbiol Infect 2000, 6:509-515.
28. Gupta K, Hooton TM, Stamm WE: Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001, 135:41-50.
29. Kluytmans J, Van Belkum A, Verbrugh H: Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997, 10(3):505-520.
30. Kahlmeter G, Menday P: Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother 2003, 52:128-131.
31. Beerepoot MA, Ter Riet G, Nys S, van der Wal WM, De Borgie CA, De Reijke TM, Prins JM, Koeijers J, Verbon A, Stobberingh E, Geerlings SE: Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med 2012, 172:704-712.
32. Bernard P: Management of common bacterial infections of the skin. Curr Opin Infect Dis 2008, 21:122-128.
33. Albrich WC, Monnet DL, Harbarth S: Antibiotic selection presssure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 2004, 10:514-517.
34. El Moussaoui R, De Borgie CAJM, Van den Broek P, Hustinx WN, Bresser P, Van den Berk GE, Poley JW, van den Berg B, Krouwels FH, Bonten MJ, Weenink C, Bossuyt PM, Speelman P, Opmeer BC, Prins JM: Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ 2006, 332:1355-1361.
35. Antimicrobial resistance surveillance in Europe. http://www.ecdc.europa. eu/en/publications/Publications/antimicrobial-resistance-surveillanceeurope-2011.pdf Accessed 8 August 2014.
36. Grol R, Wensing M: What drives change? Barriers to and incentives for achieving evidence-based practice. Med J Aust 2004, 180(Suppl):S57-S60.